Past Events – Illumina Accelerator

Partnering Forum with Illumina and Illumina Accelerator

Illumina 1:1 Meeting Opportunity:

Illumina is seeking to meet with research institutions, companies, and entrepreneurs at all stages to explore strategic partnerships, investments, and partnering opportunities.  Additionally, Illumina Accelerator is interested in meeting with startups developing breakthrough applications in genomics.

Illumina is interested in:

  • Technologies related to genomics and their applications in agriculture, biotech, and health care.
  • Applications of genomics including therapeutics, agriculture technologies, oncology, reproductive health, synthetic biology, direct to consumer, and diagnostics.
  • Bioinformatics and data analytics approaches.

BioForward Speaker Series: Illumina and Illumina Accelerator – Collaborative Innovation

In addition to partnering, BioForward hosted a morning plenary session, Illumina Accelerator panel, and networking reception on learning more about Illumina, its business development activities, and accelerator program as well as Illumina Wisconsin, formerly Epicentre Biotechnologies. Epicentre, which started in Madison in 1987, was acquired by Illumina in 2011 and has continued to expand operations in the University Research Park.

7:30 AM Registration/Networking

7:45 am – Illumina Presentation & Introduction

  • About Illumina, Illumina Wisconsin & Illumina BD

8:15 am – Illumina Accelerator Panel | Tips from 3 entrepreneurs in building genomics driven startups

  • Moderator – Amanda Cashin, PhD., Head of Illumina Accelerator
  • Will Horvat – Head Scientist (and Madison alumn), MetaMixis, Inc. |A synthetic biology company specializing in the rapid development of customized biosensors for the production of bio-based materials and chemicals.
  • Amado Guloy, PhD – CEO, REX Animal Health Inc. | A precision agriculture company commercializing a database platform for the animal health and agriculture industries.
  • Nick Conley, PhD – CEO, EpiBiome, Inc. | A venture-backed precision microbiome engineering company with the mission of developing effective and sustainable FDA-approved therapies to combat infectious disease in humans and in agriculture without the use of small-molecule antibiotics.

9:00-9:30 AM Networking


About Illumina, Inc.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit and follow @illumina.

About Illumina Accelerator
Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. It provides select startups with seed investment, business guidance, access to Illumina’s sequencing systems and reagents, and fully operational lab space in the San Francisco Bay Area during each six-month funding cycle. For more information, visit and follow

  • Illumina Partnering Forum

In Collaboration With: 


  • July 22, 2016

  • Wisconsin Institute for Discovery Building

  • Madison, WI